FFA
ANIP icon

Farther Finance Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

Farther Finance Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.78K Buy
106
+6
+6% +$481 ﹤0.01% 4509
2026
Q1 		$7.6K Buy
100
+1
+1% +$78 ﹤0.01% 4283
2025
Q4 		$7.82K Buy
99
+15
+18% +$1.3K ﹤0.01% 4070
2025
Q3 		$7.69K Buy
84
+3
+4% +$245 ﹤0.01% 3557
2025
Q2 		$5.29K Hold
81
– – ﹤0.01% 3340
2025
Q1 		$5.51K Buy
+81
New +$4.84K ﹤0.01% 3011
2024
Q2 		– Sell
-3
Closed -$204 – 3820
2024
Q1 		$204 Sell
3
-2
-40% -$121 ﹤0.01% 3270
2023
Q4 		$276 Buy
+5
New +$275 ﹤0.01% 3151

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Farther Finance Advisors's ANIP Position: Q2 2026 in Review

Farther Finance Advisors increased its ANI Pharmaceuticals (ANIP) stake by 6% in Q2 2026, buying an estimated $481 and bringing the position to 106 shares worth $8.78K. The position accounts for ﹤0.01% of the portfolio, ranked #4509.

Farther Finance Advisors first reported a position in ANIP in Q4 2023 and has held it in 8 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Farther Finance Advisors held 106 shares of ANI Pharmaceuticals worth $8.78K as of Q2 2026.
  • Farther Finance Advisors bought 6 ANI Pharmaceuticals shares in Q2 2026, an estimated $481.
  • ANI Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4509 holding.
  • Farther Finance Advisors first reported a position in ANI Pharmaceuticals in Q4 2023 and has held it in 8 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.